Literature DB >> 34150552

Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report.

Li-Yuan Rong1,2,3, Li Ran1, Shi-Ying Li1,2,4,5, Xiao-Hong Meng1,2, Yan-Ling Long1,2, Hai-Wei Xu1,2.   

Abstract

Entities:  

Year:  2021        PMID： 34150552      PMCID： PMC8165613          DOI： 10.18240/ijo.2021.06.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  22 in total

1.  Transient subretinal hemorrhage after photodynamic therapy of subfoveal choroidal osteoma.

Authors:  Melis Palamar; Onder Uretmen; Kaan Gündüz
Journal:  Retin Cases Brief Rep       Date:  2012

2.  Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.

Authors:  Ji Hun Song; Jeong Hun Bae; Mi In Rho; Sung Chul Lee
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

3.  Regression of extrafoveal choroidal osteoma following photodynamic therapy.

Authors:  Carol L Shields; Miguel A Materin; Sonul Mehta; Brett T Foxman; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2008-01

4.  Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma.

Authors:  Carol L Shields; Hong Sun; Hakan Demirci; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2005-12

5.  Bilateral choroidal osteoma with unilateral polypoidal choroidal vasculopathy treated with conbercept.

Authors:  Yan-Ming Huang; Li Zhang; Jin Liang; Rong-Di Yuan
Journal:  Int J Ophthalmol       Date:  2020-06-18       Impact factor: 1.779

6.  PHOTODYNAMIC THERAPY FOR EXTRAFOVEOLAR CHOROIDAL OSTEOMA.

Authors:  Mehdi Mazloumi; Lauren A Dalvin; David Ancona-Lezama; Arman Mashayekhi; Carol L Shields
Journal:  Retina       Date:  2020-05       Impact factor: 4.256

7.  Risk factors for retinal hemorrhage after photodynamic therapy in age-related macular degeneration.

Authors:  In Kyung Oh; Kuhl Huh; Jaeryung Oh
Journal:  Ophthalmologica       Date:  2008-11-21       Impact factor: 3.250

8.  Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study.

Authors:  Claudio Furino; Luca Di Antonio; Maria Oliva Grassi; Marco Rispoli; Michele Reibaldi; Alfredo Niro; Giovanni Alessio
Journal:  Eur J Ophthalmol       Date:  2018-08-13       Impact factor: 2.597

9.  Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma.

Authors:  Sidra Zafar; M A Burq; Mustafa Ifhtikar; Azam Ali
Journal:  Am J Ophthalmol Case Rep       Date:  2016-06-29

10.  Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab.

Authors:  Almila Sarıgül Sezenöz; Sezin Akça Bayar; Gürsel Yılmaz
Journal:  Turk J Ophthalmol       Date:  2017-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.